STOCK TITAN

LifeMD, Inc. - LFMD STOCK NEWS

Welcome to our dedicated page for LifeMD news (Ticker: LFMD), a resource for investors and traders seeking the latest updates and insights on LifeMD stock.

LifeMD, Inc. (Nasdaq: LFMD) is a leading provider of virtual primary care, offering a comprehensive and integrated telehealth solution. The company's platform connects physicians, medical providers, pharmacists, and patients through a HIPAA-compliant system, ensuring secure AES-encrypted interactions. LifeMD provides a range of services including primary care, laboratory and pharmacy services, and specialized treatment for over 200 conditions such as men’s and women’s health, weight management, allergy & asthma, and dermatology.

LifeMD operates through two segments: Telehealth and WorkSimpli, with the majority of its revenue generated from the Telehealth segment. The company’s platform integrates electronic medical records (EMR), proprietary algorithms for case-load balancing and scheduling, customer relationship management (CRM), remote and in-home lab testing, digital prescription capabilities, and cloud pharmacy fulfillment. Additionally, LifeMD offers diagnostic telehealth equipment and sells nutritional supplements and over-the-counter products.

In 2023, LifeMD achieved significant business milestones, including the launch of a GLP-1 weight management program, which rapidly scaled to over 22,000 subscribers. The company also entered a strategic alliance with Medifast, receiving a $10 million collaboration fee and a $10 million equity investment. LifeMD continues to grow its RexMD brand, focusing on expanding telehealth products and services to increase patient lifetime value.

As of the end of 2023, LifeMD reported robust financial health with cash exceeding $30 million and a strong balance sheet. The company projects a revenue growth rate above 30% for 2024, alongside improvements in adjusted EBITDA and GAAP earnings. LifeMD remains optimistic about its strategic initiatives, including the expansion of private insurance-based programs and new offerings under its partnership with Medifast.

LifeMD is dedicated to making high-quality and affordable healthcare accessible to all, leveraging its vertically-integrated, proprietary digital care platform and a 50-state affiliated medical group. Its services are available 24/7/365, ensuring that patients can manage common medical conditions conveniently and cost-effectively.

Rhea-AI Summary
LifeMD, Inc. authorizes cash dividend of $0.5546875 per share for its 8.875% Series A Cumulative Perpetual Preferred Stock, payable on October 16, 2023.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
12.42%
Tags
dividends
-
Rhea-AI Summary
LifeMD partners with ASCEND Therapeutics to provide integrated telehealth services for EstroGel® 0.06%
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.23%
Tags
none
-
Rhea-AI Summary
LifeMD, Inc. (Nasdaq: LFMD) to participate in investor conferences in September.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
5.16%
Tags
conferences
Rhea-AI Summary
LifeMD reports record quarterly revenue of $35.9 million, up 18% YoY. Telehealth net revenues increased 11% from Q1 2023. Positive free cash flow achieved. Adjusted EBITDA increased to $1.7 million from a loss of $6.9 million in the year-ago period. Weight Management program expected to be accretive in 2024. Raised 2023 revenue guidance to $146 million to $152 million. Conference call at 4:30 p.m. Eastern time today.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
19.67%
Tags
-
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-5.39%
Tags
conferences
-
Rhea-AI Summary
LifeMD, Inc. (LFMD) to Report Q2 2023 Financial Results on August 9, 2023. The leading provider of virtual primary care services will host a conference call at 4:30 p.m. Eastern time. Investors can access the live & archived webcast using the provided link.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
5.99%
Tags
conferences earnings
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
7.07%
Tags
dividends
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.66%
Tags
none
-
Rhea-AI Summary
LifeMD appoints William Febbo to its Board of Directors
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
5.64%
Tags
management
Rhea-AI Summary
LifeMD, Inc. (NASDAQ: LFMD) will participate in the virtual June 1st Investor Summit. The conference is complimentary for qualified investors.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.85%
Tags
conferences

FAQ

What is the current stock price of LifeMD (LFMD)?

The current stock price of LifeMD (LFMD) is $4.38 as of November 4, 2024.

What is the market cap of LifeMD (LFMD)?

The market cap of LifeMD (LFMD) is approximately 191.7M.

What services does LifeMD offer?

LifeMD offers virtual primary care, telemedicine, laboratory and pharmacy services, and specialized treatment for over 200 conditions.

What are the main revenue segments for LifeMD?

LifeMD operates through two segments: Telehealth and WorkSimpli, with the majority of its revenue generated from the Telehealth segment.

How does LifeMD ensure the security of patient interactions?

LifeMD uses a HIPAA-compliant platform with AES-encrypted interactions to ensure the security of communication between patients and healthcare providers.

What is the GLP-1 weight management program?

The GLP-1 weight management program is a medically supported weight loss service that has quickly become a leading provider in the nation, with over 22,000 subscribers as of 2023.

Who are LifeMD's strategic partners?

LifeMD has a strategic alliance with Medifast, which includes a $10 million collaboration fee and a $10 million equity investment.

How does LifeMD plan to grow in 2024?

LifeMD plans to expand its private insurance-based programs, launch new telehealth products under RexMD, and leverage its strategic partnership with Medifast to drive growth.

What is the financial outlook for LifeMD in 2024?

LifeMD expects a revenue growth rate above 30%, significant improvements in adjusted EBITDA, and GAAP earnings for 2024.

What types of telehealth equipment does LifeMD provide?

LifeMD provides custom-fabricated mobile diagnostic telehealth equipment such as cases, carts, and kiosks.

Is LifeMD's service available 24/7?

Yes, LifeMD's telehealth services are available 24/7/365, ensuring round-the-clock healthcare access for patients.

How does LifeMD integrate its telehealth services?

LifeMD's platform integrates electronic medical records, proprietary algorithms, customer relationship management, remote lab testing, digital prescriptions, and cloud pharmacy fulfillment.

LifeMD, Inc.

Nasdaq:LFMD

LFMD Rankings

LFMD Stock Data

191.66M
43.07M
15.57%
38.64%
12.94%
Health Information Services
Services-offices & Clinics of Doctors of Medicine
Link
United States of America
NEW YORK